Raxibacumab, medically designated as PAmAb ABthrax, is a novel treatment approach against anthrax . This monoclonal antibody , created by scientists, uniquely binds to the protective component of Bacillus anthracis, demonstrably inhibiting its capacity to trigger infection . The mechanism of Raxi